Category: Unified Patent Court
-
10x Genomics, Moderna, Novo Nordisk among newly confirmed speakers for Patent Litigation Europe event (pharma & tech) next month
Eric Whitaker, Chief Legal Officer at 10x Genomics, Karen Guo, Senior Director of Patents & IP at Novo Nordisk, and Katherine Hinterberg, Senior Director of Patent Litigation at Moderna, will speak at Kisaco Research’s annual Pharma and Biotech Patent Litigation Europe in Amsterdam.
-
U.S. and Asian companies bring vast majority of major Unified Patent Court infringement cases, reflective of EU weakness in innovation
About one third of the last 100 UPC infringement actions were brought by companies headquartered in a contracting member state, but most of them are small.
-
UPC Roundup (1 week): contempt sanctions over continued shipments; Dusseldorf LD ordered inspection at Munich trade fair; three injunctions
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our November 30, 2025 UPC Roundup.
-
Xiaomi to face off with Datang over 4G/5G SEP infringement in Munich in March 2026, successfully invalidates ASC patents in China
The Munich I Regional Court will hear Datang’s SEP infringement suit against Xiaomi on March 11, 2025, while the latter has successfully invalidated three of Advanced Standard Communication LLC’s patents in China.
-
UPC Roundup (1 week): FTO confers revocation standing; creation of transcripts based on official recording disallowed; long-arm jurisdiction without local defendant; and more
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our November 24, 2025 UPC Roundup. 1. CoA 1.1 CoA clarifies inventive step, territorial scope, and public-interest limits (Edwards v. Meril) (link to detailed article with nine takeaways for practitioners) In the long-running Edwards v. Meril dispute, a…
-
UPC Vienna LD’s first-ever final judgment led to settlement on eve of appellate hearing; intervenor’s insistence on appellate review rejected
A settlement in the home stretch to the appellate hearing suggests that the first-instance ruling from Vienna gave the patentee significant leverage.
-
Next UPC CoA landmark ruling: pragmatic on inventive-step standard; focused on when amendments could be presented; tough but fair on remedies (Edwards v. Meril)
Another major UPC appellate ruling came down on Tuesday, and it provides a variety of clarifications of transcendental importance.
-
UK judge says injunction wouldn’t affect foreign judges, InterDigital wasn’t restricted from raising arguments in UPC — yet seeks to prevent enforcement of UPC order
Mr Justice Meade and Amazon are still seeking to prevent InterDigital from enforcing a UPC injunction. In some ways there is de-escalation, but the situation remains problematic.
-
UPC CoA reverses invalidation of Amgen patent, clarifies standards for added matter and sufficient disclosure; infringement action to resume
In a high-stakes life sciences case, the UPC’s CoA has provided its most far-reaching clarifications on (in)validity to date.
-
UPC Roundup (1 week): Paris LD on starting point for urgency in special fact pattern involving acquisition of SPC; novel FRAND claim revealed; CD Munich on hindsight; and more
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our November 16, 2025 UPC Roundup. The Paris Local Division’s (LD) decision in Merz v. Viatris is discussed in particular detail.